This is a preview of subscription content, log in via an institution to check access.
Reference
Rolli FR, et al. Economic evaluation of Zepatier for the management of HCV in the Italian scenario. European Journal of Health Economics : 25 Apr 2018. Available from: URL: https://doi.org/10.1007/s10198-018-0980-4
Rights and permissions
About this article
Cite this article
Elbasvir/grazoprevir cost effective for hepatitis C in Italy. PharmacoEcon Outcomes News 803, 13 (2018). https://doi.org/10.1007/s40274-018-4940-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4940-0